BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 776494)

  • 1. Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours.
    Thomlinson RH; Dische S; Gray AJ; Errington LM
    Clin Radiol; 1976 Apr; 27(2):167-74. PubMed ID: 776494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical evaluation of ICRF 159 as a radiosensitising agent.
    Bates T
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):127-31. PubMed ID: 344288
    [No Abstract]   [Full Text] [Related]  

  • 3. The response of human tumour metastases to radiation and misonidazole.
    Dawen PJ; Peckham MJ; Steel GG
    Br J Cancer Suppl; 1978 Jun; 3():290-6. PubMed ID: 277247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour.
    Hill SA; Fowler JF
    Br J Cancer; 1977 Apr; 35(4):461-9. PubMed ID: 869984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: an interim report from the Medical Research Council Working Party on advanced carcinoma of the cervix.
    Radiother Oncol; 1993 Feb; 26(2):93-103. PubMed ID: 8465022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical testing of the radiosensitiser Ro-07-0582. II. Radiosensitisation of normal and hypoxic skin.
    Dische S; Gray AJ; Zanelli GD
    Clin Radiol; 1976 Apr; 27(2):159-66. PubMed ID: 1277732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice.
    Sheldon PW; Hill SA
    Br J Cancer; 1977 Jun; 35(6):795-808. PubMed ID: 871367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of an hypoxic cell sensitizer on tumour growth delay and cell survival. Implications for cell survival in situ and in vitro.
    McNally NJ
    Br J Cancer; 1975 Nov; 32(5):610-8. PubMed ID: 1212418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy using the hypoxic cell sensitizer Ro 03-8799 in malignant melanoma.
    Dische S
    Radiother Oncol; 1987 Oct; 10(2):111-6. PubMed ID: 2447612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations.
    Gray AJ; Dische S; Adams GE; Flockhart IR; Foster JL
    Clin Radiol; 1976 Apr; 27(2):151-7. PubMed ID: 776493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxic cell sensitisers in radiotherapy.
    Adams GE; Dische S; Fowler JF; Thomlinson RH
    Lancet; 1976 Jan; 1(7952):186-8. PubMed ID: 54693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cytotoxic effects of metronidazole and other nitro-heterocyclic drugs against hypoxic tumour cells.
    Foster JL
    Int J Radiat Oncol Biol Phys; 1978; 4(1-2):153-6. PubMed ID: 632143
    [No Abstract]   [Full Text] [Related]  

  • 13. Further investigations of the effects of the hypoxic-cell radiosensitizer, Ro-07-0582, on local control of a mouse tumour.
    Sheldon PW; Hill SA
    Br J Cancer; 1977 Aug; 36(2):198-205. PubMed ID: 911657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quantitative response of human tumours to radiation and misonidazole.
    Ash DV; Peckham MJ; Steel GG
    Br J Cancer; 1979 Dec; 40(6):883-9. PubMed ID: 526430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582.
    Denekamp J; Harris SR
    Radiat Res; 1976 Apr; 66(1):66-75. PubMed ID: 1257411
    [No Abstract]   [Full Text] [Related]  

  • 16. Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582.
    Sheldon PW; Hill SA; Foster JL; Fowler JF
    Br J Radiol; 1976 Jan; 49(577):76-80. PubMed ID: 1276579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The radiosensitizing effect of metronidazole and misonidazole (Ro-07-0582) on a human malignant melanoma grown in the athymic mutant nude mouse.
    Rofstad EK; Brustad T
    Br J Radiol; 1978 May; 51(605):381-6. PubMed ID: 638410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of tumour growth delay of fractionated and single dose irradiation when administered with misonidazole (Ro-07-0582).
    Reddy EK
    Br J Cancer Suppl; 1978 Jun; 3():250-4. PubMed ID: 277241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of tumour size on radiosensitization by misonidazole.
    Stanley JA; Peckham MJ; Steel GG
    Br J Cancer Suppl; 1978 Jun; 3():220-4. PubMed ID: 277232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
    Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.